NEW YORK (GenomeWeb) – Thermo Fisher Scientific today said that its first quarter revenues increased a fraction of 1 percent year over year. 

For the three months ended March 28, the company recorded revenues of $3.92 billion, up from $3.90 billion in the year-ago quarter, and short of the average analysts' estimate of $4.00 billion. Organic revenue growth was 2 percent year over year in the quarter, Thermo Fisher CFO Peter Wilver said on a conference call following the release of the company's financial results. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.